Possible role of methylglyoxal and glyoxalase in arthritis (Q38197360)

30 August 2017

1 reference

title

Possible role of methylglyoxal and glyoxalase in arthritis (English)

1 reference

30 August 2017

Paul J Thornalley

2

0 references

author name string

Usman Ahmed

series ordinal

1

1 reference

PubMed ID

24646275

30 August 2017

Naila Rabbani

series ordinal

3

1 reference

30 August 2017

1 April 2014

1 reference

Biochemical Society Transactions

30 August 2017

1 reference

30 August 2017

42

1 reference

30 August 2017

538-542

1 reference

30 August 2017

2

1 reference

Orthopaedic surgeon workforce and volume assessment for total hip and knee replacement in the United States: preparing for an epidemic

30 August 2017

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

Bone remodelling in osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

Relationships between biomarkers of cartilage, bone, synovial metabolism and knee pain provide insights into the origins of pain in early knee osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

Effects of aging on articular cartilage homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

Role of proinflammatory cytokines in the pathophysiology of osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

The changing face of rheumatoid arthritis: sustained remission for all?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

Extra-articular manifestations of rheumatoid arthritis: An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

Rheumatoid arthritis and the complement system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

Cytokine pathways and joint inflammation in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

Is serum anti-cyclic citrullinated peptide level useful in the diagnosis of rheumatoid arthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

Should rheumatoid factor in rheumatoid arthritis be sent to Davy Jones's Locker?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

Advanced glycation end-product (AGE)-damaged IgG and IgM autoantibodies to IgG-AGE in patients with early synovitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

Identification of the advanced glycation end products N(epsilon)-carboxymethyllysine in the synovial tissue of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

Immunohistochemical demonstration of -(carboxymethyl)lysine protein adducts in normal and osteoarthritic cartilage

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

Skin and urine pentosidine weakly correlate with joint damage in a cohort of patients with early signs of osteoarthritis (CHECK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of dia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

Central role of RAGE-dependent neointimal expansion in arterial restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

Dietary AGEs and ALEs and risk to human health by their interaction with the receptor for advanced glycation endproducts (RAGE)--an introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

Posttranslationally modified proteins as mediators of sustained intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

Identification of the receptor for advanced glycation end products in synovial tissue of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

Role of S100A12 in the pathogenesis of osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

S100A12 levels in synovial fluid may reflect clinical severity in patients with primary knee osteoarthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

Opposing roles of RAGE and Myd88 signaling in extensive liver resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

Deletion of the receptor for advanced glycation end products reduces glomerulosclerosis and preserves renal function in the diabetic OVE26 mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

Transcriptional control of glyoxalase 1 by Nrf2 provides a stress-responsive defence against dicarbonyl glycation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

NF-kappaB/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

The advanced glycation end product pentosidine correlates to IL-6 and other relevant inflammatory markers in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

Quantitative analysis of crosslinks pyridinoline and pentosidine in articular cartilage of patients with bone and joint disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

Urinary pentosidine does not predict cartilage loss among subjects with symptomatic knee OA: the BOKS Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140024

21 January 2018

Identifiers

DOI

10.1042/BST20140024

1 reference

30 August 2017

1 reference

PubMed ID

24646275